Table 1 Demographics and clinical features of children and adults with COVID-19.

Results are presented as means ± SD. n, number; COPD, chronic obstructive pulmonary disease.

Age <24 (n = 65)*Age >24 (n = 60)P value
Age13.34 ± 6.0961.05 ± 12.96<0.0001
Male:female (n)41:2434:260.47
Black:white:other/unknown (n)25:5:3530:7:230.22
Hispanic (n, %)26 (40%)15 (25%)0.09
BMI27.19 ± 14.0929.78 ± 5.610.198
Underlying medical conditions (n)
Obesity (BMI > 30)18210.44
Diabetes mellitus8200.0056
Asthma or COPD18120.40
Hypertension335<0.0001
Treatment (n)
Hydroxychloroquine947<0.0001
Remdesivir840.37
Systemic corticosteroid1480.25
IVIG100<0.0001
Other biologics45>0.99
Outcome
LOS (days)§6.37 ± 5.9114.77 ± 16.68<0.0001
Mechanical ventilation (n, %)5 (7.7%)22 (36.7%)<0.0001
Deaths (n, %)2 (3.1%)17 (28.3%)0.0001

*Includes 20 patients with MIS-C.

†Continuous variables were compared by Student’s t test; categorical variables were compared by Fisher’s exact test.

‡Other biologics include tocilizumab, sarilumab, and anakinra.

§LOS excludes patients who died.